{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:47:29Z","timestamp":1792122449549,"version":"4.4.0"},"reference-count":25,"publisher":"Massachusetts Medical Society","issue":"4","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2021,1,28]]},"DOI":"10.1056\/nejmoa2029554","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T10:39:13Z","timestamp":1605523153000},"page":"316-324","source":"Crossref","is-referenced-by-count":599,"title":["Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation"],"prefix":"10.1056","volume":"384","author":[{"given":"Oussama M.","family":"Wazni","sequence":"first","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopi","family":"Dandamudi","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh","family":"Sood","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hoyt","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaret","family":"Tyler","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfraz","family":"Durrani","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Niebauer","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Makati","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair","family":"Halperin","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Gauri","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Morales","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Shao","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Cerkvenik","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle E.","family":"Kaplon","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Nissen","sequence":"additional","affiliation":[{"name":"From Cleveland Clinic, Cleveland (O.M.W., M.N., M.S., S.E.N.), and Ohio State University Medical Center, Columbus (J.T.); CHI Franciscan, Tacoma, WA (G.D.); Southcoast Health System, Fall River, MA (N.S.); Iowa Heart Center, West Des Moines (R.H.); MedStar Heart and Vascular Institute, Washington, DC (S.D.); BayCare Medical Group, Tampa, FL (K.M.); Providence Saint Vincent, Portland, OR (B.H.); Spectrum Health Heart and Vascular, Grand Rapids, MI (A.G.); Grandview Medical Center, Birmingham, AL (G.M..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/CIRCEP.114.001853","article-title":"Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis.","volume":"7","author":"Rahman Khan A","year":"2014","unstructured":"Rahman Khan A, Khan S, Sheikh MA, Khuder S, Grubb B, Moukarbel GV. Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2014;7:853-860.25110162","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial.","volume":"321","author":"Packer DL","year":"2019","unstructured":"Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 2019;321:1261-1274.30874766","journal-title":"JAMA"},{"issue":"1","key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.","volume":"20","author":"Calkins H","year":"2018","unstructured":"Calkins H, Hindricks G, Cappato R, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2018;20(1):e1-e160.29016840","journal-title":"Europace"},{"key":"e_1_3_5_5_2","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).","author":"Hindricks G","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020 August 29 (Epub ahead of print).32860505","journal-title":"Eur Heart J"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.","volume":"130","author":"January CT","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130:2071-2104.24682348","journal-title":"Circulation"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/jce.14000","article-title":"Diagnosis-to-ablation time in atrial fibrillation: a modifiable factor relevant to clinical outcome.","volume":"30","author":"Bisbal F","year":"2019","unstructured":"Bisbal F, Alarc\u00f3n F, Ferrero-De-Loma-Osorio A, et al. Diagnosis-to-ablation time in atrial fibrillation: a modifiable factor relevant to clinical outcome. J Cardiovasc Electrophysiol 2019;30:1483-1490.31115940","journal-title":"J Cardiovasc Electrophysiol"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.hrthm.2013.05.013","article-title":"Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes.","volume":"10","author":"Bunch TJ","year":"2013","unstructured":"Bunch TJ, May HT, Bair TL, et al. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes. Heart Rhythm 2013;10:1257-1262.23702238","journal-title":"Heart Rhythm"},{"key":"e_1_3_5_9_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2019.03.036","article-title":"Early choice for catheter ablation reduced readmission in management of atrial fibrillation: impact of diagnosis-to-ablation time.","volume":"291","author":"Kawaji T","year":"2019","unstructured":"Kawaji T, Shizuta S, Yamagami S, et al. Early choice for catheter ablation reduced readmission in management of atrial fibrillation: impact of diagnosis-to-ablation time. Int J Cardiol 2019;291:69-76.30948218","journal-title":"Int J Cardiol"},{"issue":"1","key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"e003669","DOI":"10.1161\/CIRCEP.115.003669","article-title":"Radiofrequency ablation of persistent atrial fibrillation: diagnosis-to-ablation time, markers of pathways of atrial remodeling, and outcomes.","volume":"9","author":"Hussein AA","year":"2016","unstructured":"Hussein AA, Saliba WI, Barakat A, et al. Radiofrequency ablation of persistent atrial fibrillation: diagnosis-to-ablation time, markers of pathways of atrial remodeling, and outcomes. Circ Arrhythm Electrophysiol 2016;9(1):e003669-e003669.26763227","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"e_1_3_5_11_2","doi-asserted-by":"crossref","first-page":"e008128","DOI":"10.1161\/CIRCEP.119.008128","article-title":"Diagnosis-to-ablation time and recurrence of atrial fibrillation following catheter ablation: a systematic review and meta-analysis of observational studies.","volume":"13","author":"Chew DS","year":"2020","unstructured":"Chew DS, Black-Maier E, Loring Z, et al. Diagnosis-to-ablation time and recurrence of atrial fibrillation following catheter ablation: a systematic review and meta-analysis of observational studies. Circ Arrhythm Electrophysiol 2020;13(4):e008128-e008128.32191539","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation.","volume":"383","author":"Kirchhof P","year":"2020","unstructured":"Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 2020;383:1305-1316.32865375","journal-title":"N Engl J Med"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacep.2015.04.010","article-title":"A systematic review on the progression of paroxysmal to persistent atrial fibrillation: shedding new light on the effects of catheter ablation.","volume":"1","author":"Proietti R","year":"2015","unstructured":"Proietti R, Hadjis A, AlTurki A, et al. A systematic review on the progression of paroxysmal to persistent atrial fibrillation: shedding new light on the effects of catheter ablation. JACC Clin Electrophysiol 2015;1:105-115.29759352","journal-title":"JACC Clin Electrophysiol"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.","volume":"367","author":"Cosedis Nielsen J","year":"2012","unstructured":"Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012;367:1587-1595.23094720","journal-title":"N Engl J Med"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.","volume":"311","author":"Morillo CA","year":"2014","unstructured":"Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA 2014;311:692-700.24549549","journal-title":"JAMA"},{"key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.","volume":"293","author":"Wazni OM","year":"2005","unstructured":"Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005;293:2634-2640.15928285","journal-title":"JAMA"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/europace\/euu376","article-title":"Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis.","volume":"17","author":"Hakalahti A","year":"2015","unstructured":"Hakalahti A, Biancari F, Cosedis Nielsen J, Raatikainen MJ. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. Europace 2015;17:370-378.25643988","journal-title":"Europace"},{"key":"e_1_3_5_18_2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation.","volume":"374","author":"Kuck K-H","year":"2016","unstructured":"Kuck K-H, Brugada J, F\u00fcrnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 2016;374:2235-2245.27042964","journal-title":"N Engl J Med"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehy709","article-title":"A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes.","volume":"40","author":"Holmqvist F","year":"2019","unstructured":"Holmqvist F, Kesek M, Englund A, et al. A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. Eur Heart J 2019;40:820-830.30452631","journal-title":"Eur Heart J"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/eurheartj\/ehx466","article-title":"Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study.","volume":"39","author":"Langtved Pallisgaard J","year":"2018","unstructured":"Langtved Pallisgaard J, Hilmar Gislason G, Hansen J, et al. Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study. Eur Heart J 2018;39:442-449.29020388","journal-title":"Eur Heart J"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2017.11.011","article-title":"Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: two-year outcome and predictors of recurrence after a single procedure.","volume":"259","author":"Akkaya E","year":"2018","unstructured":"Akkaya E, Berkowitsch A, Zaltsberg S, et al. Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: two-year outcome and predictors of recurrence after a single procedure. Int J Cardiol 2018;259:76-81.29579615","journal-title":"Int J Cardiol"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/europace\/eur299","article-title":"Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon.","volume":"14","author":"Namdar M","year":"2012","unstructured":"Namdar M, Chierchia G-B, Westra S, et al. Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon. Europace 2012;14:197-203.21937477","journal-title":"Europace"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/europace\/euv271","article-title":"First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation.","volume":"18","author":"Straube F","year":"2016","unstructured":"Straube F, Dorwarth U, Ammar-Busch S, et al. First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation. Europace 2016;18:368-375.26504108","journal-title":"Europace"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/europace\/euz155","article-title":"Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation.","volume":"21","author":"Hoffmann E","year":"2019","unstructured":"Hoffmann E, Straube F, Wegscheider K, et al. Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation. Europace 2019;21:1313-1324.31199860","journal-title":"Europace"},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jacep.2018.11.006","article-title":"Long-term outcomes after ablation for paroxysmal atrial fibrillation using the second-generation cryoballoon: final results from STOP AF Post-Approval Study.","volume":"5","author":"Knight BP","year":"2019","unstructured":"Knight BP, Novak PG, Sangrigoli R, et al. Long-term outcomes after ablation for paroxysmal atrial fibrillation using the second-generation cryoballoon: final results from STOP AF Post-Approval Study. JACC Clin Electrophysiol 2019;5:306-314.30898232","journal-title":"JACC Clin Electrophysiol"},{"key":"e_1_3_5_26_2","first-page":"CD005049","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.","volume":"9","author":"Valembois L","year":"2019","unstructured":"Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2019;9:CD005049-CD005049.31483500","journal-title":"Cochrane Database Syst Rev"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2029554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:32:59Z","timestamp":1711485179000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2029554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,1,28]]}},"alternative-id":["10.1056\/NEJMoa2029554"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2029554","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}